Axsome Therapeutics
AXSM
AXSM
49 hedge funds and large institutions have $30.2M invested in Axsome Therapeutics in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+8
Holders Change %
+19.51%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
12
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RA
1
Royce & Associates
New York
|
$3.44M |
| 2 |
2
BlackRock
New York
|
$1.92M |
| 3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$1.56M |
| 4 |
NC
4
Nexthera Capital
New York
|
$1.56M |
| 5 |
OPPM
5
Opus Point Partners Management
New York
|
$1.04M |
